Canopy Growth (CGC) Tax Provisions (2019 - 2025)
Canopy Growth (CGC) reported Tax Provisions of $626016.3 for Q4 2025, up 176.74% on a YoY basis from $226208.3 in Q4 2024, and up 302.58% sequentially from $155499.9 in Q3 2025.
Canopy Growth (CGC) Tax Provisions (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Tax Provisions data on file, last reported at $626016.3 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 176.74% year-over-year to $626016.3; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (down 68.87% YoY), and the FY2026 full-year result was $47398.4, down 99.05% from the prior year.
- Tax Provisions grew to $626016.3 in Q4 2025, from $155499.9 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $9.6 million in Q3 2023 to a low of -$612.8 million in Q1 2023.
- A 5-year average of -$49.2 million and a median of $210018.3 in 2025 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 347.39% in 2022 and plunged 9077.44% in 2023, its largest moves.
- Tracing CGC's Tax Provisions over 5 years: stood at -$145180.5 in 2021, then plunged by 577.94% to -$984235.1 in 2022, then rose by 19.62% to -$791094.8 in 2023, then soared by 128.59% to $226208.3 in 2024, then soared by 176.74% to $626016.3 in 2025.
- Business Quant data shows CGC's Tax Provisions at $626016.3 in Q4 2025, $155499.9 in Q3 2025, and $210018.3 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 626,016.33 |
| Sep 30, 2025 | 155,499.89 |
| Jun 30, 2025 | 210,018.34 |
| Dec 31, 2024 | 226,208.33 |
| Sep 30, 2024 | 221,382.13 |
| Jun 30, 2024 | 4.53 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -791,094.76 |
| Sep 30, 2023 | 9.56 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | -612.81 Mn |
| Dec 31, 2022 | -984,235.13 |
| Sep 30, 2022 | 6.30 Mn |
| Jun 30, 2022 | 2.94 Mn |
| Mar 31, 2022 | -6.68 Mn |
| Dec 31, 2021 | -145,180.50 |
| Sep 30, 2021 | -2.55 Mn |
| Jun 30, 2021 | 2.36 Mn |
| Mar 31, 2021 | -338.29 Mn |
| Dec 31, 2020 | -11.97 Mn |